Estimating past, present, and future trends in the global distribution and abundance of the arbovirus vector Aedes aegypti under climate change scenarios
Liu-Helmersson, J., Brännström, Å., Sewe, M.O., Semenza, J.C., Rocklöv, J.
Increased risk for autochthonous vector-borne infections transmitted by aedes albopictus in continental europe
Gossner, C.M., Ducheyne, E., Schaffner, F.
- Chikungunya virus disease
- Japanese encephalitis virus
- La Réunion
- Pacific regions
- Prevention and control
- Public health threat
- United Kingdom
- Vector-borne disease
- West Nile virus infection
- Yellow fever
- Zika virus disease
Increased risk of yellow fever infections among unvaccinated European travellers due to ongoing outbreak in Brazil, july 2017 to March 2018
Gossner, C.M., Haussig, J.M., de Bellegarde de Saint Lary, C., Kaasik Aaslav, K., Schlagenhauf, P., Sudre, B.
Need for additional capacity and improved capability for molecular detection of yellow fever virus in European Expert Laboratories: External Quality Assessment, March 2018
Domingo, C., Ellerbrok, H., Koopmans, M., Nitsche, A., Leitmeyer, K., Charrel, R.N., Reusken, C.B.E.M.
The European medical corps: First public health team mission and future perspectives
Haussig, J.M., Severi, E., Baum, J.H., Vanlerberghe, V., Laiseca, A., Defrance, L., Brailescu, C., Coulombier, D., Jansa, J.
Prevention and control measures for yellow fever
A safe, effective and inexpensive yellow fever attenuated vaccine, known as YF 17D, has been used for more than half a century. The vaccine is highly effective. Travelers to endemic areas are advised to check their vaccination status and get vaccinated if necessary.